Divergent Levels of LBP and TGFβ1 in Murine MSCs Lead to Heterogenic Response to TLR and Proinflammatory Cytokine Activation

Stem Cell Reviews and Reports

Volumn 10, Issue 3, 2014, Pages 376-388

  Levin, Sarit ^a   Pevsner Fischer, Meirav ^a   Kagan, Sivan ^a   Lifshitz, Hila ^a   Weinstock, Ada ^a   Gataulin, Diana ^a   Friedlander, Gilgi ^a   Zipori, Dov ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Heterogeneity; LBP; MSC; TGF 1; TLR

Indexed keywords

ACUTE PHASE PROTEIN; CARRIER PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE-BINDING PROTEIN; MEMBRANE PROTEIN; TGFB1 PROTEIN, MOUSE; TOLL LIKE RECEPTOR; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

AGONISTS; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; IMMUNOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; SECRETION (PROCESS);

ACUTE-PHASE PROTEINS; ANIMALS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MESENCHYMAL STROMAL CELLS; MICE, INBRED BALB C; MICE, INBRED C57BL; TOLL-LIKE RECEPTORS; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899984739     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-014-9498-z     Document Type: Article

References (37)

1. Friedenstein, A. J., et al. (1974). Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Experimental Hematology, 2(2), 83-92.
2. Pittenger, M. F., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284(5411), 143-147.
3. Friedenstein, A. J., Piatetzky, S., II, & Petrakova, K. V. (1966). Osteogenesis in transplants of bone marrow cells. Journal of Embryology and Experimental Morphology, 16(3), 381-390.
4. Dexter, T. M., Allen, T. D., & Lajtha, L. G. (1978). Factors controlling the proliferation of haemopoietic stem cells in vitro. The Symposium/The Society for Developmental Biology, 35, 149-160.
5. Zhang, J., et al. (2003). Identification of the haematopoietic stem cell niche and control of the niche size. Nature, 425(6960), 836-841.
6. Hackney, J. A., et al. (2002). A molecular profile of a hematopoietic stem cell niche. Proceedings of the National Academy of Sciences of the United States of America, 99(20), 13061-13066.
7. Tse, W. T., et al. (2003). Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation, 75(3), 389-397.
8. Krampera, M., et al. (2003). Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood, 101(9), 3722-3729.
9. Nauta, A. J., et al. (2006). Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. Journal of Immunology, 177(4), 2080-2087.
10. Corcione, A., et al. (2006). Human mesenchymal stem cells modulate B-cell functions. Blood, 107(1), 367-372.
11. Sotiropoulou, P. A., et al. (2006). Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells, 24(1), 74-85.
12. Shake, J. G., et al. (2002). Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Annals of Thoracic Surgery, 73(6), 1919-1925. discussion 1926.
13. Mackenzie, T. C., & Flake, A. W. (2001). Human mesenchymal stem cells persist, demonstrate site-specific multipotential differentiation, and are present in sites of wound healing and tissue regeneration after transplantation into fetal sheep. Blood Cells, Molecules & Diseases, 27(3), 601-604.
14. Francois, S., et al. (2006). Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage. Stem Cells, 24(4), 1020-1029.
15. Lu, D., et al. (2001). Intraarterial administration of marrow stromal cells in a rat model of traumatic brain injury. Journal of Neurotrauma, 18(8), 813-819.
16. Chopp, M., et al. (2000). Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport, 11(13), 3001-3005.
17. Pevsner-Fischer, M., Levin, S., & Zipori, D. (2011). The origins of mesenchymal stromal cell heterogeneity. Stem Cell Reviews and Reports, 7, 560-568.
18. Aubin, J. E. (1998). Bone stem cells. Journal of Cellular Biochemistry. Supplement, 30-31, 73-82.
19. Banfi, A., et al. (2000). Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Experimental Hematology, 28(6), 707-715.
20. Muraglia, A., Cancedda, R., & Quarto, R. (2000). Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. Journal of Cell Science, 113(Pt 7), 1161-1166.
21. Sarugaser, R., et al. (2009). Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy. PLoS One, 4(8), e6498.
22. Chen, F. G., et al. (2007). Clonal analysis of nestin(-) vimentin(+) multipotent fibroblasts isolated from human dermis. Journal of Cell Science, 120(Pt 16), 2875-2883.
23. Okamoto, T., et al. (2002). Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells. Biochemical and Biophysical Research Communications, 295(2), 354-361.
24. Russell, K. C., et al. (2010). In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells, 28(4), 788-798.
25. Pevsner-Fischer, M., et al. (2012). Stable changes in mesenchymal stromal cells from multiple myeloma patients revealed through their responses to Toll-like receptor ligands and epidermal growth factor. Stem Cell Reviews, 8(2), 343-354.
26. Romieu-Mourez, R., et al. (2009). Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. Journal of Immunology, 182(12), 7963-7973.
27. Wang, Z. J., et al. (2009). Lipopolysaccharides can protect mesenchymal stem cells (MSCs) from oxidative stress-induced apoptosis and enhance proliferation of MSCs via Toll-like receptor(TLR)-4 and PI3K/Akt. Cell Biology International, 33(6), 665-674.
28. Opitz, C. A., et al. (2009). Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2, 3-dioxygenase-1 via interferon-beta and protein kinase R. Stem Cells, 27(4), 909-919.
29. Liotta, F., et al. (2008). Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. Stem Cells, 26(1), 279-289.
30. Yu, S., et al. (2008). Role of MyD88 in TLR agonist-induced functional alterations of human adipose tissue-derived mesenchymal stem cells. Molecular and Cellular Biochemistry, 317(1-2), 143-150.
31. Hwa Cho, H., Bae, Y. C., & Jung, J. S. (2006). Role of toll-like receptors on human adipose-derived stromal cells. Stem Cells, 24(12), 2744-2752.
32. Nemeth, K., et al. (2009). Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nature Medicine, 15(1), 42-49.
33. Pevsner-Fischer, M., et al. (2007). Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood, 109(4), 1422-1432.
34. Irizarry, R. A., et al. (2003). Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics, 4(2), 249-264.
35. Lacey, D. C., et al. (2009). Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation. Osteoarthritis and Cartilage, 17(6), 735-742.
36. Muta, T., & Takeshige, K. (2001). Essential roles of CD14 and lipopolysaccharide-binding protein for activation of toll-like receptor (TLR)2 as well as TLR4 Reconstitution of TLR2- and TLR4-activation by distinguishable ligands in LPS preparations. European Journal of Biochemistry, 268(16), 4580-4589.
37. Thomas, C. J., et al. (2002). Evidence of a trimolecular complex involving LPS, LPS binding protein and soluble CD14 as an effector of LPS response. FEBS Letters, 531(2), 184-188.